4HF is devoted to the pursuit of groundbreaking anti-cancer treatments that exhibit enhanced precision in targeting tumor cells, thereby minimizing adverse effects on patients’ health. For our innovative research approach, we have established, the CancerDataMiner™, a one-of-a-kind platform that synergizes cancer data, computational sciences, and AI-driven drug discovery.
At the forefront of our endeavors lies a pioneering project aimed at enhancing the delivery of chemotherapeutics to cancer cells, leveraging the cutting-edge concept of Small Molecule Drug Conjugates (SMDCs).
News
View all newsNEW! Freiburg, 28th March 2024. Discover the latest from 4HF Biotec at the AACR Annual meeting in San Diego. 4HF will present two exciting posters showcasing its newest advancements in the bioinformatic identification of targets and how its in silico tools can work in tandem with experimental data to gather insights about drug conjugates….
READ MORE